Seelos Therapeutics, Inc. (SEEL) Financials

NASDAQ Currency in USD Disclaimer

$0.00

Last update: 07:00 PM EST
Day's range
$0
Day's range
$0
$20M$20M$0$0-$20M-$20M-$40M-$40M-$60M-$60M-$80M-$80MEarning201720172018201820192019202020202021202120222022202320230%0%-5000%-5000%-10000%-10000%-15000%-15000%-20000%-20000%-25000%-25000%Profit Margin
Profit Margin
Revenue
Earnings

SEEL Income statement / Annual

Last year (2023), Seelos Therapeutics, Inc.'s total revenue was $2.20 M, and the percentage change from the previous year is not available. In 2023, Seelos Therapeutics, Inc.'s net income was -$37.88 M. See Seelos Therapeutics, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017 FY-2016 FY-2015 FY-2014
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Operating Revenue $2.20 M $0.00 $0.00 $0.00 $375.00 K $0.00 $0.00 $5.76 M $4.84 M $9.26 M
Cost of Revenue $30.12 M $53.00 K $0.00 $0.00 $22.56 M $0.00 $117.00 K $3.89 M $922.00 K $918.00 K
Gross Profit -$27.91 M -$53.00 K $0.00 $0.00 -$22.19 M $0.00 -$117.00 K $1.87 M $3.92 M $8.34 M
Gross Profit Ratio -12.67 0 0 0 -59.17 0 0 0.32 0.81 0.9
Research and Development Expenses $30.12 M $58.62 M $46.65 M $10.98 M $22.56 M $1.22 M $3.46 M $6.83 M $14.65 M $21.29 M
General & Administrative Expenses $12.59 M $12.30 M $15.02 M $7.78 M $7.56 M $7.93 M $7.21 M $8.43 M $10.52 M $11.42 M
Selling & Marketing Expenses -$57.00 K $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Selling, General & Administrative Expenses $12.53 M $12.30 M $15.02 M $7.78 M $7.56 M $7.93 M $7.21 M $8.43 M $10.52 M $11.42 M
Other Expenses $0.00 -$3.02 M $230.00 K $0.00 -$375.00 K $1.00 K $77.00 K -$22.00 K -$64.00 K $82.00 K
Operating Expenses $12.59 M $70.92 M $61.67 M $18.76 M $29.75 M $9.15 M $10.67 M $15.27 M $25.17 M $30.90 M
Cost And Expenses $42.70 M $70.92 M $61.67 M $18.76 M $29.75 M $9.15 M $10.67 M $19.16 M $26.09 M $31.82 M
Interest Income $198.00 K $121.00 K $113.00 K $45.00 K $151.00 K $0.00 $0.00 $0.00 $0.00 $0.00
Interest Expense $75.00 K $14.00 K $1.60 M $164.00 K $29.00 K $0.00 $83.00 K $1.02 M $845.00 K $339.00 K
Depreciation & Amortization $57.00 K $53.00 K $61.67 M $18.76 M $41.00 K $41.00 K $117.00 K $106.00 K $300.00 K $170.00 K
EBITDA -$37.75 M -$73.47 M $0.00 $0.00 -$29.33 M -$3.14 M -$10.56 M -$6.11 M -$17.83 M -$21.97 M
EBITDA Ratio -17.14 0 0 0 -78.21 0 0 -1.06 -3.68 -2.37
Operating Income Ratio -18.38 0 0 0 -79.33 0 0 -2.33 -4.41 -2.44
Total Other Income/Expenses Net $2.62 M -$2.62 M -$4.38 M -$342.00 K -$21.51 M $5.74 M -$1.08 M $5.96 M $2.33 M $82.00 K
Income Before Tax -$37.88 M -$73.53 M -$66.05 M -$19.10 M -$50.88 M -$9.22 M -$11.75 M -$7.43 M -$19.02 M -$22.48 M
Income Before Tax Ratio -17.2 0 0 0 -135.68 0 0 -1.29 -3.93 -2.43
Income Tax Expense $0.00 $2.60 M $1.49 M $119.00 K -$497.00 K -$70.00 K -$11.91 M $1.00 M $781.00 K -$691.00 K
Net Income -$37.88 M -$76.14 M -$67.53 M -$19.22 M -$50.38 M -$9.24 M $321.00 K -$7.43 M -$19.02 M -$21.79 M
Net Income Ratio -17.2 0 0 0 -134.35 0 0 -1.29 -3.93 -2.35
EPS -7.73 -21.48 -22.29 -12.88 -74.43 -89.97 24.32 -67.41 -3442.83 -165
EPS Diluted -7.73 -21.48 -22.29 -12.88 -74.43 -89.97 24.32 -67.41 -3442.83 -165
Weighted Average Shares Out $4.90 M $3.54 M $3.03 M $1.49 M $676.96 K $102.72 K $13.20 K $110.27 K $5.53 K $132.04 K
Weighted Average Shares Out Diluted $4.90 M $3.54 M $3.03 M $1.49 M $676.96 K $102.72 K $13.20 K $110.27 K $5.53 K $132.04 K
Link